Jan 21, 2020

AgeX Therapeutics anticipates a ‘revolution’ in aging in next 10 years

Posted by in categories: biotech/medical, life extension

AgeX Therapeutics Inc (NYSEAMERICAN: AGE) CEO Michael West sat down with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. The Alameda, California biotechnology company is developing a cell therapy treatment for metabolic disorders such as Type 2 diabetes.

Comments are closed.